Category: NYSE:SPY

How A Small Scottish Biotech Firm Could Win A Decisive Battle Against Cancer?

By Simon Constable, Contributor in Forbes, NASDAQ:NCNA, NYSE:IBB, NYSE:SPY, NYSE:XBI, NYSE:XLV
October 29, 2018

Nasdaq-listed Nucana has some promising cancer therapies in drug trials and an experienced leader.

How Trade War Fears Are Boosting Small Caps

By Simon Constable, Contributor in Forbes, NASDAQ:AAPL, NASDAQ:FB, NYSE:GLD, NYSE:IWM, NYSE:SPY
July 23, 2018

They’ve outpaced the large caps recently for a variety of reasons.